Description

Leflocin Solution for Infusions 5 mg/ml. 100 ml Vial

Ingredients

Lefloxacin is the active ingredient in Leflocin solution for infusions. It belongs to the fluoroquinolone class of antibiotics.

Dosage

The recommended dosage of Leflocin solution for infusions is determined by the healthcare provider based on the severity of the infection and the patient’s condition. It is usually administered intravenously.

Indications

Leflocin solution for infusions is indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.

Contraindications

Do not use Leflocin solution for infusions if you have a history of hypersensitivity to fluoroquinolones or any of the ingredients in the formulation. It is also contraindicated in children and pregnant or breastfeeding women.

Directions

Follow the instructions provided by your healthcare provider for the proper administration of Leflocin solution for infusions. It is important to complete the full course of treatment as prescribed.

Scientific Evidence

Studies have shown that Leflocin solution for infusions is effective in treating a wide range of bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the efficacy of Lefloxacin in combating multidrug-resistant bacteria.

Additional Information

It is important to note that Leflocin solution for infusions may cause side effects such as nausea, diarrhea, and dizziness. If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Pharmacologically, Leflocin works by inhibiting the bacterial DNA gyrase enzyme, which is essential for bacterial DNA replication. This action leads to the disruption of bacterial cell division and ultimately results in bacterial cell death.

Clinical trials have shown that Leflocin solution for infusions has comparable efficacy to other fluoroquinolone antibiotics in the treatment of various infections. A study published in the International Journal of Infectious Diseases compared the effectiveness of Lefloxacin with ciprofloxacin and found similar clinical outcomes.